FAME 2 Trial: FFR-Guided PCI vs. Medical Therapy – Long-Term Outcomes

Cardiovascular Center Aalst, AZORG, Aalst, Belgium

Carlos Collet, Thabo Mahendiran, Takuya Mizukami, Daniel Munhoz, Sofie Pardaens, Kazumasa Ikeda & Bernard De Bruyne

Department of Cardiology, Lausanne University Hospital, Lausanne, Switzerland

Thabo Mahendiran, Stephane Fournier & Bernard De Bruyne

Division of Cardiovascular Medicine and Stanford Cardiovascular Institute, Stanford University School of Medicine and VA Palo Alto Health Care System, Palo Alto, CA, USA

William F. Fearon

Division of Clinical Pharmacology, Department of Pharmacology, Showa University, Tokyo, Japan

Takuya Mizukami

Department of Cardiology, Catharina Hospital, Eindhoven, the Netherlands

Nico HJ Pijls, Pim AL Tonino & Mohamed El Farissi

Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands

Pim A. L. Tonino

Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy

Emanuele Barbato

Gottsegen National Cardiovascular Center, Budapest, Hungary

Zsolt Piroth

Department of Internal Medicine, University of Kragujevac, Kragujevac, Serbia

Miodrag Sreckovic

Heart Center Leipzig at University of Leipzig, Leipzig, Germany

Holger Thiele

Department of Clinical Science and Education, Unit of Cardiology, Karolinska Institute, Södersjukhuset, Stockholm, Sweden

Nils Witt

Hospices Civils de Lyon and Claude Bernard University, Lyon, France

Gilles Rioufol

Medical Faculty of Masaryk University and University Hospital Brno, Brno, Czech Republic

Petr Kala

Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Thomas Engstrom

Atlanta VA Medical Center, Emory University, Atlanta, GA, USA

Creton Mavromatis

Department of Cardiology, Örebro University Hospital, Örebro, Sweden

Be Fröbert

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark

Be Fröbert

Department of Clinical Pharmacology, Aarhus University Hospital, Aarhus, Denmark

Be Fröbert

Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark

Be Fröbert

Northeast Cardiology Associates, Bangor, ME, USA

Peter Verlee

Department of Medicine I, University Hospital Munich, Ludwig Maximilian University of Munich (LMU), Munich, Germany

Stefan Brunner

Na Homolce Hospital, Prague, Czech Republic

Martin Mates

Clinical Hospital Center Zemun, Belgrade, Serbia

Nikola Jagic

Cardiology Unit, University Hospital of Ferrara, Ferrara, Italy

Gianluca Campo

Department of Cardiology, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan

Kazumasa Ikeda

Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK

Tiago Veiga Pereira, Bruno R. da Costa & Peter Jüni